Information:
Fel:
ID
45427
Beskrivning
Principal Investigator: Mark Daly, PhD, Massachusetts General Hospital, Boston, MA, USA MeSH: Normalcy https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000630 Here, we report exome chip genotyping results of 1052 samples from the NIMH control set, a collection of healthy controls for general research use. The samples are all unrelated.
Länk
Nyckelord
Versioner (1)
- 2022-11-25 2022-11-25 - Simon Heim
Rättsinnehavare
Mark Daly, PhD, Massachusetts General Hospital, Boston, MA, USA
Uppladdad den
25 november 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000630 Exome Chip Study of NIMH Controls
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This data table contains subject IDs, consent group information and affection status.
- The data table contains mapping of study subject IDs to sample IDs and sample use.
- The subject phenotype data table includes age, race, gender, and diagnosis.
- The sample attributes data table includes body site where sample was extracted, histological type, analyte type and tumor status.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This data table contains subject IDs, consent group information and affection status.
- The data table contains mapping of study subject IDs to sample IDs and sample use.
- The subject phenotype data table includes age, race, gender, and diagnosis.
- The sample attributes data table includes body site where sample was extracted, histological type, analyte type and tumor status.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])
DNA quality was assessed by Picogreen quantification. SNP concordance and gender concordance checks were used to confirm that no significant contamination by foreign DNA was present and the samples were consistent with reported NIMH listed genders.
Item
DNA quality was assessed by Picogreen quantification. SNP concordance and gender concordance checks were used to confirm that no significant contamination by foreign DNA was present and the samples were consistent with reported NIMH listed genders.
boolean
C0012854 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
C0332306 (UMLS CUI [1,3])
C1261322 (UMLS CUI [1,4])
C0389638 (UMLS CUI [1,5])
C0752046 (UMLS CUI [1,6])
C0079399 (UMLS CUI [1,7])
C4553529 (UMLS CUI [1,8])
C1298908 (UMLS CUI [1,9])
C0750502 (UMLS CUI [1,10])
C2349974 (UMLS CUI [1,11])
C0150312 (UMLS CUI [1,12])
C0332290 (UMLS CUI [1,13])
C0027466 (UMLS CUI [1,14])
C0079399 (UMLS CUI [1,15])
C0079399 (UMLS CUI [1,2])
C0332306 (UMLS CUI [1,3])
C1261322 (UMLS CUI [1,4])
C0389638 (UMLS CUI [1,5])
C0752046 (UMLS CUI [1,6])
C0079399 (UMLS CUI [1,7])
C4553529 (UMLS CUI [1,8])
C1298908 (UMLS CUI [1,9])
C0750502 (UMLS CUI [1,10])
C2349974 (UMLS CUI [1,11])
C0150312 (UMLS CUI [1,12])
C0332290 (UMLS CUI [1,13])
C0027466 (UMLS CUI [1,14])
C0079399 (UMLS CUI [1,15])